Jun 08, 2020
CASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal Antibody Program
Jun 02, 2020
CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference
May 11, 2020
CASI Pharmaceuticals Announces First Quarter 2020 Financial Results
Apr 07, 2020
CASI Pharmaceuticals To Present at 2020 Solebury Trout Virtual Investor Conference
Dec 03, 2019
CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications
Nov 07, 2019
CASI Pharmaceuticals Enters Exclusive China Distribution License Agreement For Octreotide Long Acting Injectable (LAI) Microsphere For Neuroendocrine Cancers And Acromegaly
Sep 19, 2019
CASI Pharmaceuticals Announces The Promotion Of Larry Zhang To President
Sep 05, 2019
CASI Pharmaceuticals, Inc. to Host Key Opinion Leader Symposium on September 10, 2019 in New York City
Sep 03, 2019
CASI Pharmaceuticals, Inc. To Present At The 2019 H.C. Wainwright 21st Annual Global Investment Conference
Aug 09, 2019
CASI Pharmaceuticals Announces Second Quarter and First Half 2019 Financial and Business Results
Jun 17, 2019
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
Jun 03, 2019
CASI Pharmaceuticals To Present At The 2019 BIO International Convention
May 15, 2019
CASI Pharmaceuticals Announces First Quarter 2019 Financial and Business Results
Apr 02, 2019
CASI Pharmaceuticals Announces The Appointment Of Wei-Wu He, Ph.D., Executive Chairman, To The Role Of Chief Executive Officer
Mar 07, 2019
CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Registration Trial For MARQIBO®
Feb 19, 2019
CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN®
Feb 06, 2019
CASI Pharmaceuticals to Present at the BIO CEO & Investor Conference
Dec 03, 2018
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®)
Nov 16, 2018
CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi, China
Nov 14, 2018
CASI Pharmaceuticals Announces Third Quarter and First Nine Months 2018 Financial and Business Results